Kosiborod MN, Abildstrm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, Hovingh GK, Kitzman DW, Lindegaard ML, Mller DV, Shah SJ, Treppendahl MB, Verma S, Abhayaratna A, Ahmed FZ, Chopra V, Ezekowitz J, Fu M, Ito H, Lelonek M, Melenovsky V, Merkely B
Possible Side Effects GHK-Cu has been generally well-tolerated in research and cosmetic studies
Its mechanisms are broad and systemic, meaning it can benefit tissues throughout the body
The descriptive analyses showed the prevalence of non-melanoma skin cancer (ICD-10-GM C44) and the prescription rate of insured persons with at least one prescription of HCT and/or ACE inhibitors for the year 2010 (ATC codes: hydrochlorothiazide C03AA03